Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Aug 17 2022

Full Issue

White House Said To Plan Extending Covid Health Emergency

Another three months of special powers are incoming if the Biden administration goes ahead, as reports say it will, and renews the covid public health emergency. Meanwhile, the Atlantic notes that even as fall is incoming — bringing potentially more covid — people think the pandemic is over.

Axios: COVID Public Health Emergency Appears To Be Headed For Extension

The Biden administration appears headed toward extending the COVID-19 public health emergency for another three months, allowing special powers and programs to continue past the midterm election. (Bettelheim, 8/16)

The Atlantic: Even The CDC Is Acting Like The Pandemic Is Functionally Over 

All of this is happening as the Northern Hemisphere barrels toward fall—a time when students cluster in classrooms, families mingle indoors, and respiratory viruses go hog wild—the monkeypox outbreak balloons, and the health-care system remains strained. The main COVID guardrail left is a request for people to stay up to date on their vaccines, which most in the U.S. are not; most kids under 5 who have opted for the Pfizer vaccine won’t even have had enough time to finish their three-dose primary series by the time the school year starts. (Wu, 8/16)

On the rise of the BA.5 subvariant —

CIDRAP: Omicron Subvariant BA.5 Now Makes Up 89% Of US COVID-19 Infections

The Centers for Disease Control and Prevention's (CDC's) Nowcast variant tracker estimates that BA.5 now accounts for 88.8% of new US COVID-19 cases, while BA.4 accounts for 5.3% and BA.4.6 accounts for 5.1% of new cases. Four weeks ago BA.5 made up 74.0% of COVID-19 cases, and 2 weeks ago it accounted for 84.5%. (8/16)

In other covid news —

The Hill: Most In New Poll Say They Didn’t Take COVID Precautions Before Vacations

Few Americans who reported taking a vacation in the past three months took extra steps to avoid a COVID-19 infection prior to their trip, according to a new Axios-Ipsos poll. The poll found that exactly half of the respondents reported taking a vacation or trip in the past three months. (Schonfeld, 8/16)

AP: California Appeals Court Rejects COVID-19 Fines For Church

A California church that defied safety regulations during the COVID-19 pandemic by holding large religious services won’t have to pay about $200,000 in fines, a state appeals court ruled. (8/17)

On developments in vaccines —

Bloomberg: What Is Bivalent Vaccine? New Moderna Omicron Covid Booster Explained

Moderna says the drug triggered a strong immune response against the original virus and BA.1 subvariant. It also generated a good immune response against omicron’s latest subvariants BA.4 and BA.5., according to the UK government. However, these are findings from laboratory studies that look at levels of disease-fighting antibodies, which is just a proxy for protection in the real world. There’s no solid data yet from human trials showing this booster demonstrates superior protection against omicron infections compared to the existing shots. (Millson and Lyu, 8/16)

The New York Times: Why A Century-Old Vaccine Offers New Hope Against Pathogens

The results were dramatic: only one — or slightly more than 1 percent — of the 96 people who had received the B.C.G. doses developed Covid, compared with six — or 12.5 percent — of the 48 participants who received dummy shots. Although the trial was relatively small, “the results are as dramatic as for the Moderna and Pfizer mRNA vaccines,” said Dr. Denise Faustman, the study’s lead author and director of immunobiology at Massachusetts General Hospital. (Caryn Rabin, 8/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF